Show simple item record

dc.date.accessioned2021-04-23T18:55:15Z
dc.date.available2021-04-23T18:55:15Z
dc.date.issued2021-04-26
dc.identifier.citationRegulatory System Strengthening in the Americas. Lessons Learned from the National Regulatory Authorities of Regional Reference. Washington, D.C.: Pan American Health Organization; 2021. License: CC BY-NC-SA 3.0 IGO.en_US
dc.identifier.isbn978-92-75-12344-7 (PDF)
dc.identifier.isbn978-92-75-12343-0 (Print)
dc.identifier.urihttps://iris.paho.org/handle/10665.2/53793
dc.description.abstractImproving access to safe, effective, and quality medicines and other health technologies is a critical public health priority and a fundamental requisite for universal health. National regulatory systems play a key part in a country’s health system by overseeing the safety, quality, and efficacy of all health technologies, including pharmaceuticals, vaccines, blood and blood products, and medical devices, among others. The aim of this document is to better understand the regulatory landscape of the Americas, with an emphasis on Latin American National Regulatory Authorities of Reference. This report presents data and analysis corresponding to essential regulatory functions and systems foundations to understand current practices, identify critical issues, and present a series of recommendations for action. The report also includes an overview of the market outlook and economic integration mechanisms in the Americas and their influence on regulatory policy and pharmaceutical trade. In addition, the report includes a supplement to describe salient regulatory emergency responses to the COVID-19 pandemic in the Americas. Through this report, the Pan American Health Organization aims to increase the understanding of national regulatory remits and capacity in the Americas, raise awareness and appreciation of the regional regulatory progress and challenges, identify the regulatory issues emerging markets will bring, and highlight opportunities for evidence-based regulatory system strengthening.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectAccess to Essential Medicines and Health Technologiesen_US
dc.subjectQuality of Health Careen_US
dc.subjectPublic Healthen_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirus Infectionsen_US
dc.subjectPandemicsen_US
dc.subjectEmergency Respondersen_US
dc.subjectEmergenciesen_US
dc.subjectPharmacovigilanceen_US
dc.subjectBetacoronavirusen_US
dc.subjectHealth Systemsen_US
dc.subjectHealth Servicesen_US
dc.titleRegulatory System Strengthening in the Americas. Lessons Learned from the National Regulatory Authorities of Regional Referenceen_US
dc.typeProcedures, manuals, guidelinesen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.relation.languageVersion10665.2/53794
paho.contributor.departmentHealth Systems and Services (HSS)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO